IL44526A - Imidazole and pyridine derivatives with an additional heterocyclic ring - Google Patents

Imidazole and pyridine derivatives with an additional heterocyclic ring

Info

Publication number
IL44526A
IL44526A IL7444526A IL4452674A IL44526A IL 44526 A IL44526 A IL 44526A IL 7444526 A IL7444526 A IL 7444526A IL 4452674 A IL4452674 A IL 4452674A IL 44526 A IL44526 A IL 44526A
Authority
IL
Israel
Prior art keywords
imidazole
heterocyclic ring
pyridine derivatives
additional heterocyclic
additional
Prior art date
Application number
IL7444526A
Other languages
English (en)
Other versions
IL44526A0 (en
Original Assignee
Smith Kline & French Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline & French Lab Inc filed Critical Smith Kline & French Lab Inc
Publication of IL44526A0 publication Critical patent/IL44526A0/xx
Publication of IL44526A publication Critical patent/IL44526A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL7444526A 1973-05-03 1974-03-29 Imidazole and pyridine derivatives with an additional heterocyclic ring IL44526A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2106373A GB1419994A (en) 1973-05-03 1973-05-03 Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
GB3555173 1973-07-26

Publications (2)

Publication Number Publication Date
IL44526A0 IL44526A0 (en) 1974-06-30
IL44526A true IL44526A (en) 1979-05-31

Family

ID=26255089

Family Applications (1)

Application Number Title Priority Date Filing Date
IL7444526A IL44526A (en) 1973-05-03 1974-03-29 Imidazole and pyridine derivatives with an additional heterocyclic ring

Country Status (18)

Country Link
US (1) US3932644A (cs)
JP (1) JPS5855145B2 (cs)
AU (1) AU477220B2 (cs)
BE (1) BE814032A (cs)
CA (1) CA1041108A (cs)
CH (1) CH605917A5 (cs)
DE (1) DE2421548A1 (cs)
ES (1) ES425936A1 (cs)
FI (1) FI62301C (cs)
FR (1) FR2227869B1 (cs)
GB (1) GB1419994A (cs)
HU (1) HU168863B (cs)
IE (1) IE40014B1 (cs)
IL (1) IL44526A (cs)
IN (1) IN138721B (cs)
NL (1) NL7404811A (cs)
SE (1) SE416299B (cs)
SU (1) SU719500A3 (cs)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578459A (en) * 1973-05-03 1986-03-25 Smithkline & French Laboratories Limited Heterocyclic alkylaminoheterocycles
JPS5239976U (cs) * 1975-09-12 1977-03-22
US4145546A (en) 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
US4218452A (en) 1975-10-02 1980-08-19 Smith Kline & French Laboratories Limited Substituted 4-pyrimidone compounds, compositions and methods of use
IN146736B (cs) * 1975-10-02 1979-08-25 Smith Kline French Lab
US4216318A (en) * 1975-12-29 1980-08-05 Smith Kline & French Laboratories Limited Heterocyclic alkyl 4-pyrimidones
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
US4649138A (en) * 1976-05-14 1987-03-10 Smithkline & French Laboratories Limited Pharmaceutical compositions
US4378365A (en) * 1976-05-14 1983-03-29 Smith Kline & French Laboratories Limited Pharmaceutical compositions
NZ186511A (en) * 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
ZA782129B (en) 1977-04-20 1979-03-28 Ici Ltd Hertocyclic derivatives
US4539207A (en) * 1978-02-13 1985-09-03 Smith Kline & French Laboratories Limited Pyrimidine compounds
IN151188B (cs) * 1978-02-13 1983-03-05 Smith Kline French Lab
AU527202B2 (en) * 1978-04-11 1983-02-24 Smith Kline & French Laboratories Limited 2-aminopyrimidones
AR228941A1 (es) * 1978-04-26 1983-05-13 Glaxo Group Ltd Procedimiento para preparar nuevos derivados de 3,5-diamino-1,2,4-triazol que son activos contra receptores histaminicos
DE2963363D1 (en) 1978-05-24 1982-09-09 Ici Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4584384A (en) * 1978-05-30 1986-04-22 Smith Kline & French Laboratories Limited Nitro pyrroles
ZA792608B (en) * 1978-05-30 1980-06-25 Smith Kline French Lab Nitro compounds
ZA792607B (en) * 1978-05-30 1980-07-30 Smith Kline French Lab Nitro compounds
IL57415A (en) * 1978-05-30 1984-08-31 Smith Kline French Lab Nitropyrrole compounds,process for preparing them and pharmaceutical compositions containing them
PT69886A (en) * 1978-07-15 1979-08-01 Smith Kline French Lab Process for preparing isoureas and isothioureas
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
US4374836A (en) 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
EP0014057B1 (en) 1979-01-18 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
US4256743A (en) * 1979-02-22 1981-03-17 President And Fellows Of Harvard College Inhibition of bone resorption with H1 -blocking antihistamines
PH18379A (en) * 1979-03-02 1985-06-19 Glaxo Group Ltd Triazole acylamines and pharmaceutical compositions thereof
JPS55120571A (en) * 1979-03-02 1980-09-17 Glaxo Group Ltd Heterocyclic derivative
AU531142B2 (en) * 1979-04-04 1983-08-11 Smith Kline & French Laboratories Limited 2 amino- pyimindones
DE3067564D1 (en) * 1979-10-22 1984-05-24 Glaxo Group Ltd 1,2,4-triazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
IL61233A (en) * 1979-10-24 1984-08-31 Smith Kline French Lab Guanidino thiazolylalkylamino(alkylthioalkylamino)nitro pyrroles,process for their preparation and pharmaceutical compositions containing them
IL61234A (en) * 1979-10-24 1984-03-30 Smith Kline French Lab Guanidino thiazolyl alkylamino(alkylthioalkylamino)nitrotetrahydropyridines,process for preparing them and pharmaceutical compositions containing them
CH655104A5 (fr) * 1980-02-28 1986-03-27 Glaxo Group Ltd Derives heterocycliques triazoliques, procedes pour leur preparation et compositions pharmaceutiques les comportant.
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
US4439609A (en) * 1980-10-01 1984-03-27 Smith Kline & French Laboratories Limited Pyridines
US4352933A (en) * 1981-02-06 1982-10-05 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
US4439437A (en) * 1981-04-28 1984-03-27 Smith Kline & French Laboratories Limited 2-[2-Thiazolyl or 2-guanidino-4-thiazolyl methylthioethyl(or butyl)amino]-3-(hydroxy or carboxy)pyridines, compositions containing same and method of use
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
US4525477A (en) * 1981-12-02 1985-06-25 Smith Kline & French Laboratories Limited 2-Thiazolyl, isothiazolyl, oxazolyl and isoxazolyl alkylamino-3-nitro-heterocyclic compounds
EP0102026A3 (en) * 1982-08-20 1984-05-16 Hoechst Uk Limited Thiazole derivatives
EP0104611A3 (en) * 1982-09-28 1985-06-12 Hoechst Uk Limited Thiatriazine derivatives
JO1275B1 (en) * 1982-12-03 1985-04-20 هنري براون ثوماس Chemical process
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
PT77856B (en) * 1982-12-23 1986-04-16 Smith Kline French Lab Pyridine derivatives
EP0112704B1 (en) * 1982-12-23 1987-10-07 Smith Kline & French Laboratories Limited Pyridine derivatives
GB8311443D0 (en) * 1983-04-27 1983-06-02 Smith Kline French Lab Chemical compounds
GB8318638D0 (en) * 1983-07-09 1983-08-10 Smith Kline French Lab Chemical compounds
GB8328907D0 (en) * 1983-10-28 1983-11-30 Smith Kline French Lab Chemical compounds
GB8332091D0 (en) * 1983-12-01 1984-01-11 Smith Kline French Lab Chemical compounds
GB9715814D0 (en) 1997-07-25 1997-10-01 Black James Foundation Histamine H3 receptor ligands
GB2344588B (en) * 1997-07-25 2001-11-14 Black James Foundation 1H-4(5)-substituted imidazole derivatives their preparation and their use as histamine H 3 receptor ligands
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758759A (fr) * 1969-11-12 1971-05-10 Merck & Co Inc Pyridones anti-inflammatoires
US3853897A (en) * 1971-07-16 1974-12-10 Merck & Co Inc Certain 1-substituted-3-amino-1(2h)pyridones

Also Published As

Publication number Publication date
BE814032A (fr) 1974-10-22
US3932644A (en) 1976-01-13
FI62301C (fi) 1982-12-10
JPS5025565A (cs) 1975-03-18
NL7404811A (cs) 1974-11-05
DE2421548A1 (de) 1974-11-21
IE40014L (en) 1974-11-03
IE40014B1 (en) 1979-02-28
AU477220B2 (en) 1976-10-21
FI62301B (fi) 1982-08-31
HU168863B (cs) 1976-07-28
GB1419994A (en) 1976-01-07
ES425936A1 (es) 1976-09-16
JPS5855145B2 (ja) 1983-12-08
FR2227869B1 (cs) 1978-07-21
CA1041108A (en) 1978-10-24
IN138721B (cs) 1976-03-20
AU6859874A (en) 1975-11-06
FR2227869A1 (cs) 1974-11-29
IL44526A0 (en) 1974-06-30
SU719500A3 (ru) 1980-02-29
SE416299B (sv) 1980-12-15
CH605917A5 (cs) 1978-10-13

Similar Documents

Publication Publication Date Title
IL44526A (en) Imidazole and pyridine derivatives with an additional heterocyclic ring
IL45006A0 (en) Heterocyclic guanidine derivatives
PH9846A (en) Heterocyclic anilids
CY969A (en) 2-anilino-nicotinic and derivatives
CA977348A (en) N-susbtituted heterocyclic derivatives and preparation thereof
IL44045A0 (en) 2-(phenoxyalkylthio) imidazole derivatives and their preparation
EG11106A (en) Heterocyclic anilids
ZA741979B (en) Basically substituted heterocyclic derivatives
CA1016180A (en) Basically substituted benzimidazol derivatives
ZA741498B (en) Imidazo heterocyclic derivatives
ZA741401B (en) Imidazole derivatives
IL45877A (en) 4-oxo-1-pyridinyl-penicillin and cephalosporin derivatives
GB1483621A (en) Rifamycin derivatives
PH10322A (en) Nitroimidazole derivatives
IL41017A0 (en) Imidazole derivatives of rifamycin
AU6722674A (en) Formamidine derivatives
AU479257B2 (en) Imidazo heterocyclic derivatives
CA875568A (en) Heterocyclic derivatives
AU6727774A (en) Substituted heterocyclic derivatives
CA843953A (en) Heterocyclic derivatives of triphenylethylenes, triphenylethanes and triphenylethanols
CA824677A (en) Heterocyclic derivatives of triphenylethylenes, triphenylethanes and triphenylethanols
CA850664A (en) Heterocyclic derivatives
CA788461A (en) Ring e heterocyclic derivatives of yohimbanes
AU452326B2 (en) Heterocyclic derivatives
AU1471970A (en) Heterocyclic derivatives